Published: 05 August 2025 . The English Chronicle Desk. The English Chronicle Online
As the popularity of weight-loss injections continues to surge across the UK, the National Health Service (NHS) is being called upon to take a more comprehensive and long-term approach to supporting patients once they have completed their course of treatment. A new set of official guidelines from the National Institute for Health and Care Excellence (NICE) is pushing for the NHS to monitor and assist these patients for at least a year after they stop taking the drugs, in a bid to prevent the common problem of weight regain.
According to the guidance, the NHS must not treat the conclusion of weight-loss medication or behavioural therapy as the endpoint of care. Rather, it should mark the beginning of a crucial transition phase requiring structured support to sustain the positive lifestyle changes achieved during treatment. NICE warns that without continued assistance, many individuals who lose weight using fat jabs are at significant risk of regaining it in the months following cessation.
An estimated 1.5 million people across the UK are currently using weight-loss injections, such as semaglutide, with most obtaining the treatments privately due to limited NHS availability. However, under the new “quality standard” introduced by NICE, those who do receive treatment through the NHS should be offered extended follow-up support, including personalised behavioural advice, digital self-monitoring tools, access to peer networks, and community-based resources.
Professor Jonathan Benger, Deputy Chief Executive and Chief Medical Officer at NICE, emphasised the importance of maintaining continuity of care beyond pharmacological intervention. “Successful weight management doesn’t end when medication stops or when someone completes a behavioural programme,” he said. “We know that the transition period after treatment is crucial, and people need structured support to maintain the positive changes they’ve made. This new standard ensures that services deliver the continuity of care required to secure lasting outcomes.”
NICE’s recommendations are aligned with the NHS’s broader 10-year strategy to evolve from a reactive “sickness service” into a proactive “health service” focused on prevention. This includes empowering individuals to adopt sustainable lifestyle habits that promote long-term health and wellbeing.
The updated guidance encourages NHS providers to watch for signs of creeping weight gain and to collaborate with patients in formulating practical, evidence-based strategies—such as “if-then” planning—so that individuals know how to respond if weight starts to return. It also advises helping patients make lasting changes to their dietary routines, physical activity levels, and even shopping habits, to reinforce the behavioural foundation needed for maintaining a healthy weight.
Dr Rebecca Payne, who chairs NICE’s Quality Standards Advisory Committee, noted that weight loss must be seen as a lifelong commitment, not a temporary intervention. “The evidence is clear: advice and support for maintaining weight after stopping medication or completing behavioural interventions can help prevent weight regain and enable people to experience lasting benefits,” she said. “This quality standard will help ensure all healthcare providers adopt these best practices, giving every person the best chance of maintaining their weight management success over the long term.”
Meanwhile, Professor Kamila Hawthorne, Chair of the Royal College of General Practitioners, also welcomed the guidelines, highlighting that weight-loss medication is not suitable for everyone and carries potential health risks. She stressed that there is no universal solution to obesity and that a personalised, holistic approach is essential for long-term success. “Weight-loss drugs mustn’t be seen as a silver bullet. Ensuring access to sufficient wraparound services—particularly when patients stop medication—will be key to achieving optimal health outcomes.”
In response, an NHS spokesperson reiterated the organisation’s commitment to integrated weight management services. “While these new treatments are excellent at supporting weight loss, they’re not a magic bullet and must be paired with wraparound support including advice on healthier diets and physical activity to see sustainable results. The NHS is already supporting hundreds of thousands of people to lose weight through our 12-week digital weight management programme, and we are expanding this to reach 125,000 more people per year as part of the 10-year health plan.”
The new NICE standard represents a clear shift toward embedding weight management within a framework of long-term preventive healthcare, where medications are only one part of a much larger strategy. It reinforces the belief that lasting change is only possible when supported by sustained, individualised, and holistic care—delivered not just at the start of the journey, but throughout the lifelong effort to stay healthy.
